Our Products
All
Products
Please Select
Afdol
Afoxin
Algocin
Anafortan Plus
Analar
Axid Neo
Ceclor
Chymoral Forte
Co-Maledox
Doxium
Esi-Dep
Floxigem
Gluconorm
Gluconormet
Kefadim
Keflex
Kefzol
Lucast
Magnofenac
Magnus MR
Maxna
Melfax
Merlon
Nebcin
Osnate Suspension
Osnate Tablet
Osnate-D Suspension
Osnate-D Tablet
Phyllocontin
Posterisan
Posterisan forte
Poze
Poze G
Pozemet
Rigix
Rubifer
Rubifer-F
Rubiject Injection
Sinaxamol
Sinaxamol Extra
Spasler Neo
Spasler P
Tojina
Toni-5
Xotivir
Xovat
List of Generics
Please Select
Aminophylline Hydrate
Artemether
Bacterial Culture Suspension
Bromazepam
Calcium Dobesilate
Calcium gluconoglucoheptonate
Cefaclor
Cefazolin
Ceftazidime
Cephalexin
Cetirizine Dihydrochloride
Chymotrypsin
Ciprofloxacin
Clarithromycin
Diclofenac Sodium
Dimethyl amino ethanol
Entecavir
Escitalopram Oxalate
Esomeprazole Magnesium
Folic acid
Gemifloxacin mesylate
Glimepiride
Hydrocortisone
Hyoscine Butyl Bromide
Iron Polymaltose Complex
Iron sucrose
Lumefantrine
Lysine Monohydrate
Mebeverine HCl
Meloxicam
Memantine HCl
Metformin HCl
Montelukast sodium
Morphine Sulphate
Orlistat
Orphenadrine Citrate
Ossein Mineral Complex
Paracetamol
Phloroglucinol
Phosphoric acid
Pioglitazone HCl
Rosuvastatin calcium
Sorbitol
Tizanidine
Tobramycin Sulphate
Tramadol HCl
Tranexamic acid
Trimethylphloroglucinol
Trypsin
Ursodeoxycholic acid
Therapeutic Classes
Please Select
Anti Alzheimers
Anti-inflammatory enzyme
Antiallergics
Antiasthmatics
Antibiotics
Antidepressant
Antidiabetic
Antifibrinolytic
Antihaemorrhoidals
Antilipidemic
Antimalarial
Antiobesity
Antispasmodics
Antiviral
Anxiolytic
Bile therapy & cholagogue
Calcium Preparation
Iron preparations
Muscle relaxants
Narcotic analgesic
Non narcotic analgesic
NSAIDs
Proton Pump Inhibitor
Tonic
Venotropic Agent
PRODUCT
Algocin
Generic:
Ciprofloxacin
Therapeutic Class:
Antibiotics
Composition:
Each Algocin tablet contains ciprofloxacin HCl, H2 O (USP) equivalent to Ciprofloxacin 250 mg and 500 mg tablets
Description:
Algocin is a synthetic broad spectrum antibacterial agent for oral administration.
Indications:
Urinary tract infection Chronic bacterial prostatitis Lower respiratory tract infection Acute sinusitis Skin and skin structure infections Bone & joint infections Complicated intra-abdominal infections (used in combination with metronidazole) Infectious diarrhea Typhoid & para typhoid Uncomplicated cervical and urethral gonorrhea Acute uncomplicated cystitis in females Inhalational anthrax (post-exposure)
Dosage:
Location of infection Severity Unit Dose Frequency Usual Durations Urinarytract infections Acute uncomplicated 250 mg q 12 h 3 days Mild/moderate 250 mg q 12 h 7 to 14 days Severe/complicated 500 mg q 12 h 7 to 14 days Chronic Bacterial Prostatitis Mild/moderate 500 mg q 12 h 28 days Lower Respiratory Tract Mild/moderate 500 mg q 12 h 7 to 14 days Severe/complicated 750 mg q 12 h 7 to 14 days Acute Sinusitis Mild/moderate 500 mg q 12 h 10 days Skin and Skin Structure Mild/moderate 500 mg q 12 h 7 to 14 days Severe/complicated 750 mg q 12 h 7 to 14 days Bone and Joint Mild/moderate 500 mg q 12 h 4 to 6 weeks Severe/complicated 750 mg q 12 h 4 to 6 weeks Intra-Abdominal* Complicated 500 mg q 12 h 7 to 14 days Infectious Diarrhea Mild/moderate/severe 500 mg q 12 h 5 to 7 days Typhoid Fever Mild/moderate 500 mg q 12 h 10 days Urethral and Cervical Uncomplicated 250 mg single dose Single dose Inhalational anthrax (post-exposure) 500 mg q 12 h 60 days
* used in conjunction with metronidazole
Presentations:
250 mg tabs 10’s
